USP14 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the phosphorylation of USP14 (S241) was substantially reduced in PtPT-treated CML cells (Figure 1d), also indicative of suppression of the DUB activity of USP14 by PtPT treatment.37